Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2017 at "Current Hematologic Malignancy Reports"
DOI: 10.1007/s11899-017-0418-6
Abstract: Purpose of ReviewOver the past decade, the pathogenic role of mutations in isocitrate dehydrogenases (IDH) 1 and 2, affecting approximately 20% of patients with AML, has been defined, allowing for the development of specific therapeutic… read more here.
Keywords: mutations acute; idh1 idh2; idh2 mutations; myeloid leukemia ... See more keywords